Signing of the Convalescent Plasma Clinical Trial Research Agreement Document

• Posted by: Admin
• Selasa, 27 Oktober 2020
• Has been read 121 time(s)

Tuesday, 27 October 2020

In connection with the research activity of Clinical Trials of Convalescent Plasma as Additional Therapy for Corona Virus Disease 10 (Covid-19)-PlaSenTer, today (Tuesday, 27/10/2020) at the Meeting Room of UNUD Hospital, Building 2, 3rd floor, the event took place signing:

1. Research Cooperation Agreement between the Research and Development Center for Health Resources and Services and Udayana University Hospital regarding Clinical Trials of Convalescent Plasma Administration as Supplementary Therapy for Corona Virus Disease 19 (Covid-19).

2. Research Cooperation Agreement between the Center for Research and Development of Health Resources and Services and Sanglah Hospital regarding Clinical Trials of Convalescent Plasma Administration as Additional Therapy for Corona Virus Disease 19 (Covid-19).

The event was attended by the Head of the Research and Development Center for Health Resources & Services, DR. dr. Irmansyah, Sp.KJ (K), Dean of the Faculty of Medicine, Udayana University who on this occasion was represented by the Deputy Dean for Student Affairs and Information Dr. dr. I Made Sudarmaja, M. Kes., Director of Udayana University Hospital Prof. Dr. dr. Dewa Putu Gde Purwa Samatra, Sp.S (K)., Director of Human Resources and Education at Sanglah Hospital, Dr. dr. Ketut Surya Negara Sp.OG (K), MARS., Head of LPPM Udayana University Prof. Dr. Ir. Gede Rai Maya Temaja, MP, Heads of Heads and Heads of Hospitals. Udayana University, the PlaSenter Research Team at Udayana University Hospital and the PlaSenter Research Team at the Research and Development Agency.

In addition to the signing of the Cooperation Agreement, an initial check of the completeness of documents and research facilities was also carried out as well as giving directions by Dr. dr. Irmansyah, Sp.KJ (K) as the Head of the Research and Development Center for Health Resources and Services. It is hoped that with this collaboration, Udayana University Hospital can actively participate in Clinical Trials of Convalescent Plasma Therapy as Supplementary Therapy for Corona Virus Disease 19 (Covid-19).

Gallery